Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C14H19N3S.3C4H4O4 |
Molecular Weight | 870.988 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 3 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.OC(=O)\C=C\C(O)=O.CN(C)CCN(CC1=CC=CS1)C2=CC=CC=N2.CN(C)CCN(CC3=CC=CS3)C4=CC=CC=N4
InChI
InChIKey=OLGIEIJNOQGBSS-VQYXCCSOSA-N
InChI=1S/2C14H19N3S.3C4H4O4/c2*1-16(2)9-10-17(12-13-6-5-11-18-13)14-7-3-4-8-15-14;3*5-3(6)1-2-4(7)8/h2*3-8,11H,9-10,12H2,1-2H3;3*1-2H,(H,5,6)(H,7,8)/b;;3*2-1+
Molecular Formula | C14H19N3S |
Molecular Weight | 261.386 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C4H4O4 |
Molecular Weight | 116.0722 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
DescriptionSources: http://www.drugbank.ca/drugs/DB04819
Sources: http://www.drugbank.ca/drugs/DB04819
Methapyrilene is an antihistamine and anticholinergic of the pyridine chemical class which was developed in the early 1950s. It was sold under the trade names Co-Pyronil and Histadyl EC. It has relatively strong sedative effects, to the extent that its primary use was as a medication for insomnia rather than for its antihistamine action. Together with scopolamine, it was the main ingredient in Sominex, Nytol, and Sleep-Eze. It also provided the sedative component of Excedrin PM. Manufacturers voluntarily withdrew methapyrilineb drug products from the market in May and June 1979, when methapyrilene was demonstrated to cause liver cancer in rats when given chronically.
Approval Year
Doses
Dose | Population | Adverse events |
---|---|---|
2.5 g single, oral Overdose |
healthy, 19 years |
Other AEs: Dizziness, Stomach cramps... |
25 mg single, intravenous Dose: 25 mg Route: intravenous Route: single Dose: 25 mg Sources: |
healthy, 20 - 35 years Health Status: healthy Age Group: 20 - 35 years Sex: M+F Sources: |
|
50 mg single, oral |
healthy, 20 - 35 years Health Status: healthy Age Group: 20 - 35 years Sex: M+F Sources: |
AEs
AE | Significance | Dose | Population |
---|---|---|---|
Delusions | 2.5 g single, oral Overdose |
healthy, 19 years |
|
Dizziness | 2.5 g single, oral Overdose |
healthy, 19 years |
|
Stomach cramps | 2.5 g single, oral Overdose |
healthy, 19 years |
PubMed
Title | Date | PubMed |
---|---|---|
Toxicology of vancomycin in laboratory animals. | 1981 Nov-Dec |
|
The carcinogenic effect of methapyrilene combined with nitrosodiethylamine given to rats in low doses. | 1992 Jul |
|
Effects of induction and inhibition of cytochromes P450 on the hepatotoxicity of methapyrilene. | 1998 Nov |
|
Principal component analysis of mass spectra of peptides generated from the tryptic digestion of protein mixtures. | 2001 |
|
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. | 2001 Aug 15 |
|
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. | 2001 Mar 31 |
|
Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. | 2001 Sep |
|
Morphological transformation of Syrian hamster embryo cells at pH 6.7 by bemitradine, a nongenotoxic carcinogen. | 2001 Summer |
|
Non-genotoxic carcinogens: early effects on gap junctions, cell proliferation and apoptosis in the rat. | 2002 Dec 2 |
|
Cross-site comparison of gene expression data reveals high similarity. | 2004 Mar |
|
Interlaboratory evaluation of rat hepatic gene expression changes induced by methapyrilene. | 2004 Mar |
|
Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression. | 2004 Mar |
|
Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. | 2005 Aug 4 |
|
Tissue distribution of quetiapine in 20 cases in Virginia. | 2006 May |
|
Identification of genes implicated in methapyrilene-induced hepatotoxicity by comparing differential gene expression in target and nontarget tissue. | 2007 Apr |
|
Literature-based compound profiling: application to toxicogenomics. | 2007 Nov |
|
Identification of the thiophene ring of methapyrilene as a novel bioactivation-dependent hepatic toxicophore. | 2008 Aug |
|
A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats. | 2008 Aug 19 |
|
Primary rat hepatocytes as in vitro system for gene expression studies: comparison of sandwich, Matrigel and 2D cultures. | 2008 Dec |
|
Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens. | 2010 Dec |
|
Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat. | 2011 Nov |
|
Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens. | 2012 Aug |
|
Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver. | 2012 Sep |
|
Pharmacokinetics explain in vivo/in vitro discrepancies of carcinogen-induced gene expression alterations in rat liver and cultivated hepatocytes. | 2013 Feb |
|
Disruption of spindle checkpoint function ahead of facilitation of cell proliferation by repeated administration of hepatocarcinogens in rats. | 2015 Dec |
|
Assessment of global and gene-specific DNA methylation in rat liver and kidney in response to non-genotoxic carcinogen exposure. | 2015 Dec 1 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/2046705
Methapyrilene failed to induce formation of DNA adducts in L5178Y cell DNA at doses which induced mutations at the thymidine kinase locus. These data suggest that methapyrilene induces mutations in this system through an indirect genotoxic mechanism; e.g., via an oxidative mechanism or interaction with chromosomal proteins.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:18 GMT 2023
by
admin
on
Fri Dec 15 15:01:18 GMT 2023
|
Record UNII |
KJ5I25TXYL
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
33032-12-1
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
SUB14535MIG
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
C83953
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
KJ5I25TXYL
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
m7301
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000076549
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
251-351-3
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
CHEMBL1411979
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
DTXSID0047404
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
6436730
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY | |||
|
DBSALT002793
Created by
admin on Fri Dec 15 15:01:18 GMT 2023 , Edited by admin on Fri Dec 15 15:01:18 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |